Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01675232 · ClinicalTrials.gov registry record · NA

A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis

A NA study of Atopic Dermatitis, sponsored by Yale University.

Completed
Registry status
NA
Development phase
45
Enrollment target
1
Study location

NCT01675232 is a NA study of Atopic Dermatitis that has completed, run by Yale University. The registered enrollment target is 45 participants, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01675232, a NA study of Atopic Dermatitis, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the efficacy of two different corticosteroid ointment application regimens for the treatment of eczema (atopic dermatitis).

Conditions Studied

Interventions

  • OTHER Soak and smear
  • OTHER Dry Smear

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2012-07
Est. Completion 2013-07
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT01675232

The ClinicalTrials.gov registry entry for NCT01675232 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 609-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (93% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Atopic Dermatitis appearing as the primary indexed condition, and to 2 interventions - of which Soak and smear is the first listed.

NCT01675232 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT01675232 about?

NCT01675232 is a clinical study titled "A Study Comparing the Efficacy of Two Topical Steroid Application Regimens in Pediatric Patients With Atopic Dermatitis". The purpose of this study is to investigate the efficacy of two different corticosteroid ointment application regimens for the treatment of eczema (atopic dermatitis).

What is the current status of trial NCT01675232?

This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2012-07. Estimated completion is 2013-07.

What conditions does trial NCT01675232 study?

This clinical trial studies the following conditions: Atopic Dermatitis.

What interventions are being tested in trial NCT01675232?

The interventions under investigation include: Soak and smear (OTHER), Dry Smear (OTHER).

Who is sponsoring clinical trial NCT01675232?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01675232 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Atopic Dermatitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.